Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance

• Main Authors: Lopez, J.E, Yeo, K, Caputo, G, Buonocore, M, Schaefer, S
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: beta adrenergic receptor blocking agent; dipeptidyl carboxypeptidase inhibitor; gadolinium pentetate; methamphetamine; central stimulant agent; contrast medium; diagnostic agent; adult; arterial oxygen saturation; article; blood pressure measurement; cardiomyopathy; cardiovascular magnetic resonance; cardiovascular system examination; case report; cell damage; clinical evaluation; contrast enhancement; convalescence; disease association; disease severity; emergency ward; female; heart function; heart left ventricle hypertrophy; heart muscle cell; human; medical history; nuclear magnetic resonance imaging; paroxysmal dyspnea; peripheral edema; physical examination; prediction; priority journal; prognosis; smoking; systolic heart murmur; thorax radiography; tobacco; two dimensional echocardiography; chemically induced disorder; electrocardiography; fibrosis; heart left ventricle function; heart muscle; hospitalization; pathology; pathophysiology; prediction and forecasting; time; treatment outcome; Adult; Cardiomyopathies; Central Nervous System Stimulants; Contrast Media; Electrocardiography; Female; Fibrosis; Gadolinium DTPA; Humans; Magnetic Resonance Imaging, Cine; Methamphetamine; Myocardium; Predictive Value of Tests; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/183272
• Institution: National University of Singapore

10.1186/1532-429X-11-46